Copy
CPF Newsletter January 28
View this email in your browser

CPF Virtual Education Series

Live attendees eligible to receive CME and MOC Part 2 Credit
View Past CPF Education Videos

"Febrile Infants Clinical Practice Guidlines"
Thursday, Feb. 3 | 6 PM

Donald Arnold, MD, MPH, Professor of Pediatrics, Division of Emergency Medicine, Vanderbilt University Medical Center, will be leading a talk on Thursday, Feb. 3 at 6 PM over Zoom discussing the new clinical practice guidelines for febrile infants.
Febrile Infants CME Presentation - Register HERE
New AAP Guidelines - Febrile Infants 8-60 Days Old

"Myocarditis and COVID-19 Update"
Tuesday, Feb. 22 | 6 PM

English Flack, MD, MS, Associate Professor of Clinical Pediatrics, Division of Pediatric Cardiology, Vanderbilt University Medical Center, will be leading a presentation on Tuesday, Feb. 22 at 6 PM over Zoom on the latest data and information on COVID-19 and Myocarditis.
Myocarditis CME Presentation - Register HERE
Return to Play Guidelines - Algorithm

Sign-Up Now for CPF's Annual Meeting!

April 19 at the Loveless Café Barn!!
CPF's 2022 Annual Meeting for all members (Community physicians and NPs, Vanderbilt faculty, Fellows, and Residents!) is planned to be held in-person at the iconic Loveless Café Barn in Nashville!

The Annual Meeting will include a cocktail reception from 5:30 to 7 PM and a Dinner Program at 7 PM, featuring the presentation of the 2022 Excellence in Children's Health Award to former Nashville Predators Goalie Pekka Rinne and the 365 Pediatric Cancer Fund. 

The Annual Meeting is a +1 event for members (and it's FREE!). Register Now!
CPF 2022 Annual Meeting - Register HERE

Changes to Controlled Substance Monitoring Database Requirements

Changes Affect Schedule II Amphetamines
The TN Controlled Substance Monitoring Database (CSMD) rules have been amended effective this week. The amendment requires that all healthcare practitioners, unless otherwise exempted, check the CSMD prior to issuing a Schedule II amphetamine, at the beginning of a new episode of treatment; prior to the issuance of each new prescribing for the first 90 days of a new episode of treatment; and at least every 6 months during that course of treatment. 

This rule change means that Schedule II amphetamines constitute a third class of drugs (others being opioids and benzodiazepines) triggering a check and is the result of the CSMD Committee's determination that Schedule II amphetamines demonstrate a high potential for abuse. As with opioids and benzos, an authorized healthcare practitioner's delegate may check the controlled substance database on behalf of the practitioner who is prescribing Schedule II amphetamines. (Credit: Julie Loomis, RN, JD, SVMIC AVP of Risk Education)
CSMD Reporting - FAQs
CSMD Changes and Regulations

CPF Career Center: MD/NP Openings!

CPF's Career Center houses openings at member practices and, at the bottom of the page, resumes of people looking for positions in the area. If you want to add a post or have a post removed from a filled position, please email CPF Program Manager Preston Spencer at preston.spencer@vumc.org.
Nurture Pediatrics (Smyrna) - Seeking Pediatrician
University Pediatrics (Nashville) - Seeking Pediatrician
Copyright © 2022 Cumberland Pediatric Foundation, All rights reserved.


unsubscribe from this list    update subscription preferences 

Email Marketing Powered by Mailchimp